Joseph Todisco Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Joseph Todisco is Executive Vice President of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 327,194 shares of AMRX, which is worth approximately $2.75 Million. The most recent transaction as insider was on May 07, 2022, when has been sold 1,562 shares (Class A Common Stock) at a price of $3.4 per share, resulting in proceeds of $5,311. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K

0% 3M change

0% 12M change

Total Value Held $2.75 Million

Joseph Todisco Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2022	SELL Payment of exercise price or tax liability	$5,311 $3.4 p/Share	1,562 Reduced 0.48%	327,194 Class A Common Stock
May 07 2022	BUY Exercise of conversion of derivative security	-	4,442 Added 1.33%	328,756 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$58,905 $4.45 p/Share	13,237 Reduced 3.92%	324,314 Class A Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	37,655 Added 10.14%	333,645 Class A Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$50,981 $4.59 p/Share	11,107 Reduced 3.57%	299,896 Class A Common Stock
Feb 27 2022	BUY Exercise of conversion of derivative security	-	29,684 Added 8.71%	311,003 Class A Common Stock
Dec 02 2021	SELL Open market or private sale	$6,150 $4.1 p/Share	1,500 Reduced 0.53%	281,319 Class A Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$8,122 $5.2 p/Share	1,562 Reduced 0.55%	282,819 Class A Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	-	4,441 Added 1.54%	284,381 Class A Common Stock
Mar 15 2021	SELL Open market or private sale	$247,771 $6.82 p/Share	36,330 Reduced 11.49%	279,940 Class A Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$99,908 $2.75 p/Share	36,330 Added 10.3%	316,270 Class A Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$20,233 $5.18 p/Share	3,906 Reduced 1.38%	279,940 Class A Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	11,111 Added 3.77%	283,846 Class A Common Stock
Feb 27 2021	SELL Payment of exercise price or tax liability	$59,139 $5.39 p/Share	10,972 Reduced 3.87%	272,735 Class A Common Stock
Feb 27 2021	BUY Exercise of conversion of derivative security	-	29,683 Added 9.47%	283,707 Class A Common Stock

Also insider at

CRMD

CorMedix Inc. Healthcare

Chief Executive Officer

Joseph Todisco

Executive Vice President

Berkeley Heights, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account